PMID- 10636911 OWN - NLM STAT- MEDLINE DCOM- 20000224 LR - 20211203 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 275 IP - 3 DP - 2000 Jan 21 TI - Lipopolysaccharide-activated kinase, an essential component for the induction of the antimicrobial peptide genes in Drosophila melanogaster cells. PG - 2071-9 AB - Eukaryotic organisms use a similar Rel/NF-kappaB signaling cascade for the induction of innate immune genes. In Drosophila, lipopolysaccharide (LPS) signal-induced activation of the Rel/NF-kappaB family transcription factors is an essential step in the transcriptional activation of inducible antimicrobial peptide genes. However, the mechanism by which the LPS-induced signaling pathway proceeds remains largely unknown. Here we have cloned a novel Drosophila LPS-activated kinase (DLAK) that is structurally related to mammalian IkappaB kinases. DLAK is expressed and transiently activated in LPS-responsive Drosophila cells following LPS stimulation. Furthermore, DLAK can interact with Cactus, a Drosophila IkappaB and phosphorylate recombinant Cactus, in vitro. Overexpression of dominant-negative mutant DLAK (DLAK(K50A)) blocks LPS-induced Cactus degradation. DLAK-bound Cactus can be degraded in a LPS signal-dependent fashion, whereas the DLAK(K50A) mutant-bound Cactus is completely resistant to degradation in the presence of LPS. The DLAK(K50A) mutant also inhibits nuclear kappaB binding activity and kappaB-dependent diptericin reporter gene activity in a dose-dependent manner, but the kappaB-dependent diptericin reporter gene activity can be rescued by overexpression of wild type DLAK. Moreover, mRNA analysis of various kappaB-dependent antimicrobial peptide genes shows that LPS inducibility of these genes is greatly impaired in cells overexpressing DLAK(K50A). These results establish that DLAK is a novel LPS-activated kinase, which is an essential signaling component for the induction of antimicrobial peptide genes following LPS treatment in Drosophila cells. FAU - Kim, Y S AU - Kim YS AD - Laboratory of Immunology, Medical Research Center, College of Medicine, Yonsei University, Shinchon-Dong 134, Seoul, South Korea. FAU - Han, S J AU - Han SJ FAU - Ryu, J H AU - Ryu JH FAU - Choi, K H AU - Choi KH FAU - Hong, Y S AU - Hong YS FAU - Chung, Y H AU - Chung YH FAU - Perrot, S AU - Perrot S FAU - Raibaud, A AU - Raibaud A FAU - Brey, P T AU - Brey PT FAU - Lee, W J AU - Lee WJ LA - eng SI - GENBANK/AF140766 PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Anti-Infective Agents) RN - 0 (DNA-Binding Proteins) RN - 0 (Drosophila Proteins) RN - 0 (Lipopolysaccharides) RN - 0 (NF-kappa B) RN - 0 (Phosphoproteins) RN - 149059-01-8 (cact protein, Drosophila) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.10 (I-kappa B Kinase) RN - EC 2.7.11.10 (IKKbeta protein, Drosophila) SB - IM MH - Amino Acid Sequence MH - Animals MH - Anti-Infective Agents/*pharmacology MH - Cell Line MH - Chromosome Mapping MH - Cloning, Molecular MH - DNA-Binding Proteins/metabolism MH - Dose-Response Relationship, Drug MH - Drosophila Proteins MH - Drosophila melanogaster/*enzymology MH - Female MH - Genes, rel/genetics MH - I-kappa B Kinase MH - In Situ Hybridization MH - Lipopolysaccharides/*metabolism MH - Male MH - Models, Genetic MH - Molecular Sequence Data MH - NF-kappa B/chemistry MH - Phosphoproteins/metabolism MH - Protein Binding/drug effects MH - Protein Serine-Threonine Kinases/chemistry/*physiology MH - Reverse Transcriptase Polymerase Chain Reaction MH - Sequence Homology, Amino Acid MH - Signal Transduction MH - Time Factors MH - Up-Regulation EDAT- 2000/01/15 09:00 MHDA- 2000/02/26 09:00 CRDT- 2000/01/15 09:00 PHST- 2000/01/15 09:00 [pubmed] PHST- 2000/02/26 09:00 [medline] PHST- 2000/01/15 09:00 [entrez] AID - S0021-9258(18)31144-X [pii] AID - 10.1074/jbc.275.3.2071 [doi] PST - ppublish SO - J Biol Chem. 2000 Jan 21;275(3):2071-9. doi: 10.1074/jbc.275.3.2071.